CCJ

CCJ

Cameco is one of the world's largest producers of uranium, operating in the nuclear fuel industry.
As a leading global supplier, its identity is defined by its strategic importance and the significant scale of its high-grade uranium assets.

$110.79 +1.87 (+1.72%)

Updated: January 14, 2026, 16:00 EST

Analyzed by Rockflow Bobby Quantitative Model ✓ Updated Daily

Investment Opinion: Should I buy CCJ Today?

Based on the provided data, here is a comprehensive analysis of Cameco Corp. (CCJ).

Technical Analysis CCJ has shown exceptionally strong bullish momentum, significantly outperforming the market over the past several months. However, the stock is now trading near the top of its 52-week range, suggesting it is technically overbought. This elevated position indicates limited immediate upside and a higher risk of a near-term pullback or consolidation phase.

Fundamentals The company's financial health is solid due to strong liquidity and minimal debt, but its operational performance is concerning. Quarterly revenue is volatile, profitability has turned negative, and key efficiency metrics like asset turnover are weak. The extended cash conversion cycle points to underlying challenges in managing inventory and working capital.

Valuation CCJ's valuation appears severely stretched across nearly all standard metrics. Its price-to-sales ratio is extremely high, and the negative forward P/E indicates market expectations of future losses. These extreme valuations are difficult to justify based on the company's current financial performance and growth prospects.

Risk Investors face moderate volatility, with the stock being more sensitive to market swings. The substantial maximum drawdown over the past year highlights its potential for significant losses. Primary risks are linked to the volatile uranium market and the company's own operational inefficiencies.

Recommendation

Based on this analysis, a buy recommendation for CCJ is not warranted at this time. The stock's recent surge has pushed its price to overbought technical levels, while its valuation metrics signal extreme overvaluation. Although the company has a strong balance sheet, its negative profitability and operational inefficiencies do not support the current high price. Investors should wait for a more attractive entry point or clearer signs of sustained fundamental improvement before considering a position.

*Note: This is not investment advice, for reference only.*

CTA Banner

CCJ 12-Month Price Forecast

RockFlow Model Forecast: Three Scenarios for 2026

Based on current analysis, the 12-month outlook for Cameco (CCJ) is cautious. The primary catalyst remains strong long-term structural demand for nuclear fuel, driven by global energy security needs and the transition to clean energy. However, significant risks are present, including the stock's severely stretched valuation and technically overbought condition, which heighten the potential for a near-term pullback. The company's operational challenges, reflected in volatile revenue and negative profitability, further temper the immediate outlook. While analyst targets are not provided, the prevailing valuation suggests limited upside from the current price near $109, with a more attractive entry point likely needed to justify a bullish stance. Investors should monitor for improvements in operational execution and a more reasonable valuation.

Wall Street Consensus

Most Wall Street analysts are optimistic about CCJ's 12-month outlook, with consensus target around $110.79, indicating expected upside potential.

Average Target
$110.79
21 analysts
Implied Upside
+0%
vs. current price
Analyst Count
21
covering this stock
Price Range
$89 - $144
Analyst target range
Buy Buy
18 (86%)
Hold Hold
3 (14%)
Sell Sell
0 (0%)

Bulls vs Bears: CCJ Investment Factors

Overall, CCJ has investment potential but also faces challenges. Here are key factors to weigh before investing.

Bullish Bullish
  • Strong stock performance: CCJ stock has soared over 60% in 2025, showing strong investor confidence.
  • Nuclear energy momentum: Global nuclear energy buildout gaining traction, boosting long-term uranium demand.
  • Positive analyst coverage: UBS initiated coverage with a buy rating, driving recent stock gains.
  • Exceptional historical returns: Generated over 300% returns in three years, demonstrating strong growth.
  • Earnings pullback as opportunity: Recent dip viewed as buying chance amid positive long-term outlook.
Bearish Bearish
  • Post-earnings stock decline: Stock fell after earnings report, indicating potential volatility concerns.
  • Recent price correction: Share price dropped nearly 10% in one week, showing instability.
  • High expectations risk: Massive past gains may set unrealistic future performance expectations.
  • Market volatility sensitivity: Stock shows susceptibility to short-term market fluctuations and news.
  • Execution pressure: Strong growth trajectory increases pressure to meet high investor expectations.
Reward Banner

CCJ Technical Analysis

CCJ has demonstrated exceptionally strong bullish momentum with substantial gains across all measured timeframes while significantly outperforming the broader market. The stock exhibits aggressive upward price action characterized by both impressive returns and elevated volatility, reflecting its high-beta nature. This performance profile indicates strong investor conviction in the underlying fundamentals driving the advance.

Over the past one and three months, CCJ has delivered outsized returns of 13.77% and 25.59% respectively, substantially outperforming the market by 22.22% over the quarter. This pronounced short-term outperformance highlights exceptionally strong relative strength and confirms the stock's leadership status. The momentum is both significant and consistent across recent periods despite the stock's inherent volatility.

Currently trading near the upper boundary of its 52-week range at approximately 97% of its $114.45 high, the stock appears technically overbought after its sustained rally. While the proximity to the yearly peak demonstrates remarkable strength, it also suggests limited immediate upside potential and elevated near-term vulnerability to a pullback. Investors should monitor for potential consolidation or profit-taking given the extended position relative to the yearly range.

📊 Beta
1.22
1.22x market volatility
📉 Max Drawdown
-35.5%
Largest decline past year
📈 52-Week Range
$35-$114
Price range past year
💹 Annual Return
+123.0%
Cumulative gain past year
Period CCJ Return S&P 500
1m +21.1% +1.3%
3m +27.9% +5.7%
6m +54.8% +10.6%
1y +123.0% +16.5%
ytd +12.4% +1.1%

CCJ Fundamental Analysis

Revenue & Profitability CCJ exhibits uneven quarterly performance with Q3 revenue declining significantly from Q2. While Q3 maintained a solid gross margin of 37.3% (up from 29.3% in Q2), net profitability turned negative due to substantial other expenses. This volatility reflects operational challenges in translating top-line stability to bottom-line results.

Financial Health The company maintains strong liquidity with a current ratio of 2.99 and minimal debt, evidenced by a low debt-to-equity ratio of 0.15. However, the cash flow to debt ratio of 0.15 indicates modest coverage, though interest coverage remains healthy at 15.4 times, suggesting adequate servicing capacity.

Operational Efficiency Operational metrics show strain with negative returns on assets and equity in Q3, alongside a low asset turnover of 0.06. The extended cash conversion cycle of 144 days, driven by high inventory days outstanding, points to inefficiencies in working capital management that are impacting overall returns.

Quarterly Revenue
$0.6B
2025-09
Revenue YoY Growth
-14.7%
YoY Comparison
Gross Margin
37.3%
Latest Quarter
Free Cash Flow
$1.0B
Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

RockFlow Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

Try Now & Get Tesla Stock Reward

Valuation Analysis: Is CCJ Overvalued?

Valuation Level

Cameco exhibits concerning valuation metrics with a TTM PE ratio of 125.2 and an astronomical forward PE of approximately -90,402, the latter being negative due to expected losses. The stock trades at significant premiums with a PB ratio of 7.52 and a remarkably high PS ratio of 82.97, far exceeding typical norms and indicating extreme overvaluation based on current sales and book value. The extraordinarily high PEG ratio of 903.66 and EV/EBITDA of 561.64 further confirm severe overvaluation, signaling exceptionally poor earnings growth prospects relative to price and inefficient cash flow generation.

Peer Comparison

A direct peer comparison cannot be performed as the industry average data is unavailable. However, the provided metrics—particularly the extraordinarily high PS and negative forward PE—are so extreme that they would likely stand out as outliers in any industrial or materials sector. This suggests the current valuation is disconnected from fundamental performance, warranting caution regardless of specific industry benchmarks.

Current PE
127.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -90402×-946×
vs. Industry Avg
N/A
Industry PE ~N/A×
EV/EBITDA
561.6x
Enterprise Value Multiple

Investment Risk Disclosure

Volatility Risk

CCJ exhibits moderate volatility compared to the broader market, as indicated by its Beta of 1.217. This suggests the stock is approximately 22% more volatile than the market, meaning it may experience larger price swings. The notable maximum drawdown of -35.49% over the past year highlights significant downside risk, indicating that investors have faced substantial losses during recent market downturns, underscoring the stock's sensitivity to adverse conditions.

Other Risks

While the lack of significant short interest suggests that bearish sentiment is not a major immediate concern, potential risks may stem from broader industry factors such as regulatory changes, uranium price volatility, and operational challenges inherent in the mining sector. Liquidity risk appears manageable, but investors should be wary of external shocks that could impact commodity-dependent stocks like CCJ.

FAQs

Is CCJ a good stock to buy?

Bullish for long-term investors, despite near-term caution. The stock benefits from strong momentum tied to global nuclear energy adoption and positive analyst sentiment, but its extreme valuation and recent volatility suggest limited immediate upside. This makes CCJ suitable for growth-oriented investors with a high risk tolerance and a long-term horizon, who can withstand potential short-term pullbacks.

Is CCJ stock overvalued or undervalued?

Based on the provided financial metrics, Cameco (CCJ) stock appears significantly overvalued.

Key valuation metrics signaling overvaluation include an extremely high trailing PE ratio of 125.2, a massively negative forward PE, and a price-to-sales (PS) ratio of 83.0, which is extraordinarily high and indicates the market price is disconnected from current revenue generation. The price-to-book (PB) ratio of 7.5 also suggests investors are paying a large premium over the company's net asset value.

The primary reason for this overvaluation is the severe disconnect between the stock price and the company's fundamental performance. Despite maintaining liquidity, CCJ is grappling with negative profitability, operational inefficiencies (evidenced by a long cash conversion cycle), and an inability to translate revenue into earnings. The astronomical forward PE and PEG ratios reflect deeply pessimistic market expectations for future earnings growth, making the current stock price unjustifiable.

What are the main risks of holding CCJ?

Based on the provided analysis of Cameco Corporation (CCJ), here are the key inherent risks of holding the stock:

1. Operational and Commodity Price Risk: The company's negative profitability and strained operational efficiency, characterized by a long cash conversion cycle, expose it to risks from both internal execution challenges and volatility in the price of uranium. 2. Valuation and Momentum Risk: After a sustained rally that has left the stock trading near its 52-week high and technically overbought, it faces elevated vulnerability to a significant price correction or consolidation driven by profit-taking. 3. Market Volatility Risk: With a beta of 1.2, the stock is inherently more volatile than the broader market, meaning it is likely to experience larger price swings, both up and down, during periods of market turbulence.

What is the price forecast for CCJ in 2026?

Of course. Here is a professional forecast for Cameco Corp. (CCJ) stock through 2026.

**Cameco (CCJ) Stock Forecast through 2026**

1. Target Price Range: * Base Case (2026): $120 - $140 * Bull Case (2026): $160 - $190

Much of the appreciation is expected in the latter half of the forecast period as new contracts ramp up and the structural uranium supply deficit becomes more acute.

2. Key Growth Drivers: * Structural Supply Deficit: Persistent under-supply in the uranium market, driven by years of underinvestment in new mine capacity, is the primary fundamental driver for higher long-term prices. * Global Policy Shift: Increasing government support for nuclear energy as a reliable, clean baseload power, particularly in the U.S., Canada, Europe, and Asia, is creating unprecedented long-term demand visibility. * Utility Contracting Cycle: Major utilities are actively seeking long-term supply contracts to secure fuel for their existing and planned reactor fleets, which should benefit leading suppliers like Cameco with tier-one assets.

3. Main Assumptions: * The global macroeconomic environment remains stable, avoiding a deep recession. * Uranium spot prices continue their gradual upward trend, averaging above $80-$90 per pound by 2026. * Cameco successfully executes its ramp-up plan to increase production from its key sites (McArthur River/Key Lake, Cigar Lake) to meet contracted demand. * There are no major operational disruptions or significant negative shifts in nuclear energy policy.

4. Uncertainty & Risks: This forecast is highly sensitive to uranium spot prices and Cameco's operational execution. Key risks include a faster-than-expected return of Kazakh supply, a deterioration in the global economy dampening energy demand, potential project delays, and the stock's current premium valuation, which makes it vulnerable to corrections if growth narratives stall.